Arcutis Biotherapeutics (ARQT) Institutional Ownership $13.74 -0.66 (-4.58%) Closing price 06/27/2025 04:00 PM EasternExtended Trading$13.86 +0.13 (+0.91%) As of 06/27/2025 07:33 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Arcutis Biotherapeutics (NASDAQ:ARQT)Number ofInstitutional Buyers(last 12 months)136TotalInstitutional Inflows(last 12 months)$337.82MNumber ofInstitutional Sellers(last 12 months)70TotalInstitutional Outflows(last 12 months)$183.51M Get ARQT Insider Trade Alerts Want to know when executives and insiders are buying or selling Arcutis Biotherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ARQT Institutional Buying and Selling by Quarter Arcutis Biotherapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails6/18/2025 Voya Investment Management LLC29,056$454K0.0%-9.6%0.024% 6/3/2025 Inspire Investing LLC21,570$337K0.0%-25.4%0.018% 6/3/2025 Invst LLC20,652$323K0.0%N/A0.017% 5/29/2025 Rhumbline Advisers181,074$2.83M0.0%+7.7%0.152% 5/28/2025 GK Wealth Management LLC10,452$163K0.2%N/A0.009% 5/19/2025 UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC279,047$4.36M0.0%-0.4%0.234% 5/16/2025 Woodline Partners LP410,000$6.41M0.0%N/A0.344% 5/16/2025 Fred Alger Management LLC36,313$568K0.0%N/A0.030% 5/16/2025 Goldman Sachs Group Inc.1,103,413$17.26M0.0%-15.5%0.926% 5/16/2025 Scientech Research LLC55,205$863K0.2%N/A0.046% Get the Latest News and Ratings for ARQT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Arcutis Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/16/2025 Millennium Management LLC473,625$7.41M0.0%-79.5%0.397% 5/16/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.71,417$1.12M0.0%+3.0%0.060% 5/16/2025 Cormorant Asset Management LP1,350,000$21.11M1.6%-26.0%1.133% 5/16/2025 AQR Capital Management LLC248,196$3.88M0.0%+21.4%0.208% 5/16/2025 Advisors Asset Management Inc.28,187$441K0.0%+26.2%0.024% 5/16/2025 Allostery Investments LP7,500$117K0.2%N/A0.006% 5/15/2025 PDT Partners LLC317,465$4.97M0.4%-0.7%0.266% 5/15/2025 Graham Capital Management L.P.37,617$588K0.0%+40.2%0.032% 5/15/2025 Quarry LP6,500$102K0.0%-56.7%0.005% 5/15/2025 Paradigm Biocapital Advisors LP1,465,334$22.92M1.1%N/A1.229% 5/15/2025 Driehaus Capital Management LLC1,092,735$17.09M0.2%-0.4%0.917% 5/15/2025 State of Wyoming13,232$207K0.0%+228.5%0.011% 5/15/2025 MYDA Advisors LLC290,000$4.54M0.8%+45.0%0.243% 5/14/2025 PEAK6 LLC10,000$156K0.0%-50.0%0.008% 5/14/2025 Ieq Capital LLC22,082$345K0.0%N/A0.019% 5/14/2025 Rafferty Asset Management LLC160,367$2.51M0.0%-23.8%0.135% 5/14/2025 Corebridge Financial Inc.52,662$824K0.0%-1.5%0.044% 5/14/2025 Virtus Advisers LLC11,606$182K0.2%+100.0%0.010% 5/14/2025 MetLife Investment Management LLC64,485$1.01M0.0%-1.5%0.054% 5/14/2025 Jump Financial LLC42,000$657K0.0%+177.7%0.035% 5/14/2025 AlphaQuest LLC5,927$93K0.0%-17.0%0.005% 5/14/2025 Candriam S.C.A.1,035,576$16.20M0.1%-0.6%0.869% 5/14/2025 Wellington Management Group LLP46,640$729K0.0%-5.3%0.039% 5/13/2025 Northern Trust Corp976,070$15.27M0.0%-1.5%0.819% 5/13/2025 Algert Global LLC120,880$1.89M0.0%+49.6%0.101% 5/13/2025 Tocqueville Asset Management L.P.16,200$253K0.0%+14.1%0.014% 5/13/2025 American Century Companies Inc.1,652,492$25.85M0.0%+1.3%1.386% 5/13/2025 Tejara Capital Ltd846,221$13.24M5.1%-4.6%0.710% 5/13/2025 Aberdeen Group plc587,540$9.19M0.0%+21.9%0.493% 5/13/2025 Fox Run Management L.L.C.29,967$469K0.1%+76.8%0.025% Trump set to Boost Social Security Checks by 400%? (Ad)If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President Trump's Executive Order #14196 could not only save Social Security from collapse... ...but potentially increase benefits by up to 400%, according to legendary investor Louis Navellier.Click here to watch the full presentation before it's too late.5/13/2025 Cookson Peirce & Co. Inc.57,613$901K0.0%N/A0.048% 5/13/2025 Informed Momentum Co LLC215,763$3.38M0.6%N/A0.181% 5/12/2025 Nuveen LLC815,816$12.76M0.0%N/A0.684% 5/12/2025 Virtu Financial LLC68,261$1.07M0.1%N/A0.057% 5/12/2025 Entropy Technologies LP15,744$246K0.0%N/A0.013% 5/12/2025 Invesco Ltd.1,328,954$20.79M0.0%+18.0%1.115% 5/12/2025 Swiss National Bank204,000$3.19M0.0%-1.4%0.171% 5/9/2025 Deutsche Bank AG381,355$5.96M0.0%-1.6%0.320% 5/9/2025 Charles Schwab Investment Management Inc.860,768$13.46M0.0%-2.1%0.722% 5/9/2025 Vanguard Group Inc.6,818,078$106.64M0.0%+5.9%5.720% 5/9/2025 Thoroughbred Financial Services LLC59,940$937K0.1%N/A0.050% 5/9/2025 Phocas Financial Corp.103,999$1.63M0.2%N/A0.087% 5/8/2025Jefferies Financial Group Inc.86,925$1.36M0.0%-20.9%0.073% 5/8/2025 Baader Bank Aktiengesellschaft10,000$156K0.0%N/A0.008% 5/8/2025 XTX Topco Ltd73,676$1.15M0.1%N/A0.062% 5/8/2025 Federated Hermes Inc.737,555$11.54M0.0%+49.6%0.619% 5/7/2025 Essex Investment Management Co. LLC190,638$2.98M0.6%+33.5%0.160% 5/7/2025 Nkcfo LLC7,000$109K0.1%N/A0.006% 5/7/2025 LPL Financial LLC115,757$1.81M0.0%-4.2%0.097% 5/7/2025 Zurcher Kantonalbank Zurich Cantonalbank 29,697$464K0.0%+3.2%0.025% 5/6/2025 Royce & Associates LP267,612$4.19M0.0%N/A0.225% 5/6/2025 Legato Capital Management LLC56,717$887K0.1%+32.6%0.048% 5/6/2025 Readystate Asset Management LP60,200$942K0.0%N/A0.051% 5/6/2025 KLP Kapitalforvaltning AS18,500$289K0.0%-23.6%0.016% 5/5/2025 GW&K Investment Management LLC1,512,211$23.65M0.2%-2.1%1.269% 5/5/2025 Kestra Private Wealth Services LLC14,158$221K0.0%N/A0.012% 5/5/2025 Jackson Creek Investment Advisors LLC113,536$1.78M0.6%-25.0%0.095% 5/5/2025 Jennison Associates LLC11,360,875$177.68M0.1%-7.9%9.531% 5/1/2025 CWM LLC11,331$177K0.0%+88.9%0.010% 5/1/2025 New York State Common Retirement Fund48,670$761K0.0%+93.4%0.041% 4/30/2025 Cerity Partners LLC19,354$303K0.0%N/A0.016% 4/30/2025 China Universal Asset Management Co. Ltd.23,797$372K0.0%-4.1%0.020% 4/29/2025 Penserra Capital Management LLC118,521$1.85M0.0%N/A0.100% 4/29/2025 Bank of New York Mellon Corp300,031$4.69M0.0%-1.6%0.253% 4/28/2025 Teacher Retirement System of Texas28,352$443K0.0%-9.2%0.024% 4/28/2025 Vontobel Holding Ltd.13,356$209K0.0%N/A0.011% 4/25/2025 Amalgamated Bank3,723$58K0.0%+39.4%0.003% 4/25/2025 KBC Group NV5,368$84K0.0%N/A0.005% 4/24/2025 Perpetual Ltd26,520$415K0.0%N/A0.022% 4/23/2025 AMI Asset Management Corp208,721$3.26M0.2%-3.4%0.176% 4/22/2025 Fishman Jay A Ltd. MI533,150$8.34M0.9%-0.6%0.449% 4/21/2025 Silverleafe Capital Partners LLC26,208$410K0.1%N/A0.022% 4/15/2025 SG Americas Securities LLC32,566$509K0.0%-32.3%0.027% 4/9/2025 LVW Advisors LLC14,466$226K0.0%+21.2%0.012% 4/8/2025 Rhumbline Advisers181,074$2.83M0.0%+7.7%0.153% 4/7/2025 GAMMA Investing LLC15,515$2.43M0.0%+1,261.0%0.013% 3/24/2025 Wellington Management Group LLP49,267$686K0.0%-7.3%0.042% 3/17/2025 Wealth Enhancement Advisory Services LLC20,912$291K0.0%N/A0.018% 2/27/2025Jefferies Financial Group Inc.109,900$1.53M0.0%-14.3%0.094% 2/19/2025 GF Fund Management CO. LTD.2,458$34K0.0%N/A0.002% Trump set to Boost Social Security Checks by 400%? (Ad)If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President Trump's Executive Order #14196 could not only save Social Security from collapse... ...but potentially increase benefits by up to 400%, according to legendary investor Louis Navellier.Click here to watch the full presentation before it's too late.2/17/2025 UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC280,100$3.90M0.0%+1.2%0.239% 2/17/2025 Voloridge Investment Management LLC290,938$4.05M0.0%+126.5%0.249% 2/17/2025 Squarepoint Ops LLC121,392$1.69M0.0%+67.2%0.104% 2/17/2025 Two Sigma Investments LP84,844$1.18M0.0%-51.1%0.072% 2/17/2025 Suvretta Capital Management LLC11,399,138$158.79M5.4%+6.3%9.740% 2/17/2025 Sherbrooke Park Advisers LLC14,146$197K0.1%N/A0.012% 2/17/2025 Rafferty Asset Management LLC210,337$2.93M0.0%-24.0%0.180% 2/17/2025 Point72 Asset Management L.P.1,753,522$24.43M0.1%+617.5%1.498% 2/17/2025 Polar Capital Holdings Plc7,377,381$102.77M0.6%+7.2%6.303% 2/17/2025 ProShare Advisors LLC35,817$499K0.0%+32.7%0.031% (Data available from 1/1/2016 forward) ARQT Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ARQT shares? During the previous two years, 205 institutional investors and hedge funds held shares of Arcutis Biotherapeutics. The most heavily invested institutionals were Jennison Associates LLC ($177.68M), Suvretta Capital Management LLC ($158.79M), Vanguard Group Inc. ($106.64M), Polar Capital Holdings Plc ($102.77M), Rubric Capital Management LP ($101.99M), Gilder Gagnon Howe & Co. LLC ($54.37M), and State Street Corp ($52.47M).Learn more on Arcutis Biotherapeutics' institutional investors. Which institutional investors have been buying Arcutis Biotherapeutics' stock? Of the 174 institutional investors that purchased Arcutis Biotherapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Jennison Associates LLC ($10.73M), Rubric Capital Management LP ($6.75M), Franklin Resources Inc. ($3.42M), Vestal Point Capital LP ($2.70M), Opaleye Management Inc. ($1.96M), Farallon Capital Management LLC ($1.78M), and Point72 Asset Management L.P. ($1.75M). How much institutional buying is happening at Arcutis Biotherapeutics? Institutional investors have bought a total of 26,777,864 shares in the last 24 months. This purchase volume represents approximately $337.82M in transactions. Which of Arcutis Biotherapeutics' major shareholders have been selling company stock? Of the 70 institutional investors that sold Arcutis Biotherapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Millennium Management LLC ($1.84M), Farallon Capital Management LLC ($1.75M), Franklin Resources Inc. ($1.13M), Jennison Associates LLC ($978.92K), Ensign Peak Advisors Inc ($889.32K), J. Goldman & Co LP ($879.57K), and Bank of America Corp DE ($639.45K). How much institutional selling is happening at Arcutis Biotherapeutics? Institutional investors have sold a total of 13,949,148 shares in the last 24 months. This volume of shares sold represents approximately $183.51M in transactions. Related Companies LEGN Institutional Ownership GRFS Institutional Ownership TLX Institutional Ownership TGTX Institutional Ownership LNTH Institutional Ownership NUVL Institutional Ownership AXSM Institutional Ownership AKRO Institutional Ownership PCVX Institutional Ownership ADMA Institutional Ownership This page (NASDAQ:ARQT) was last updated on 6/28/2025 by MarketBeat.com Staff From Our Partners3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredIsrael-Iran WAR Could Destroy Trump's PresidencyThe missiles are already flying. Israel and Iran are now in direct military conflict — and this couldn't ha...American Alternative | SponsoredTrump set to Boost Social Security Checks by 400%?If you're currently collecting—or planning to collect—Social Security benefits, there's an urgent development ...InvestorPlace | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredA grave, grave error.Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...Porter & Company | SponsoredThe Shocking Link Between A.I. and Your MoneyThe AI boom isn’t just transforming technology—it’s redefining global power, increasing government debt, and u...Lear Capital | SponsoredBanks aren’t ready for this altcoin—are you?The Secret Crypto That Billionaires Are Hoarding When these hit, the current price will look like pocket ch...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arcutis Biotherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Arcutis Biotherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ARQT Stock Free ARQT Stock Alerts